AMD3100 Plus Pembrolizumab in Immune Checkpoint Blockade Refractory Head and Neck Squamous Cell Carcinoma
Clinical trial NCT04058145 · WITHDRAWN
Trial details
- NCT number
- NCT04058145
- Sponsor
- Massachusetts General Hospital
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-30
- Primary completion
- 2019-10-11
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.